"PHARMACEUTICAL CLUSTER TASHKENT PHARMA PARK: INNOVATIONS, INVESTMENTS, AND PROSPECTS." FOCUS ON INNOVATIVE TECHNOLOGIES AND INTERNATIONAL COOPERATION
Main Article Content
Abstract:
The article is devoted to the development of the Tashkent Pharma Park pharmaceutical cluster, one of the key projects in the pharmaceutical industry of Uzbekistan. Its role in localizing the production of drugs, introducing innovative technologies and scientific developments, and attracting international investment are considered. Particular attention is paid to international cooperation, its impact on the development of the cluster and prospects for further growth. The benefits of the project for the national economy are described, including the creation of new jobs, increased exports and support for startups. In conclusion, the significance of Tashkent Pharma Park as an important center of innovation in the pharmaceutical industry of the region is emphasized.
Article Details
How to Cite:
References:
Bazarova N. et al. Determination of the relationship between the polymorphic genes of metaloproteinases MMP9 (A-8202G) RS11697325 and the level of cystatin c in children with chronic nephritic syndrome //BIO Web of Conferences. – EDP Sciences, 2024. – Т. 121. – С. 03011.
Мамараджабова Д. Э. и др. ИЗУЧЕНИЕ И РОЛЬ ПРЕПАРАТА КОЭНЗИМА Q10 В ФАРМАЦЕВТИЧЕСКОМ КОНСУЛЬТИРОВАНИИ СРЕДИ НАСЕЛЕНИЯ //Ustozlar uchun. – 2024. – Т. 57. – №. 1. – С. 2-7.
Khabibullaevich A. B. THE EXPLORATION AND SUCCESS OF MARKETING EFFORTS BY A PHARMACEUTICAL COMPANY IN UZBEKISTAN //O'ZBEKISTONDA FANLARARO INNOVATSIYALAR VA ILMIY TADQIQOTLAR JURNALI. – 2024. – Т. 3. – №. 33. – С. 33-37.
Bekhzod A. THE STANDARD OF MODERN UZBEKISTAN PROBLEMS AND PROSPECTS. – 2024.

